Company registration number SC376094 (Scotland)
CARRON MEDICAL SERVICES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
CARRON MEDICAL SERVICES LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 3
CARRON MEDICAL SERVICES LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 MARCH 2026
31 March 2026
- 1 -
2026
2025
Notes
£
£
£
£
Current assets
Cash and cash equivalents
136,329
116,083
Current liabilities
3
(14,546)
(14,404)
Net current assets
121,783
101,679
Equity
Called up share capital
4
100
100
Retained earnings
121,683
101,579
Total equity
121,783
101,679

For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 28 May 2026 and are signed on its behalf by:
Dr G Muircroft
Director
Company registration number SC376094 (Scotland)
CARRON MEDICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
- 2 -
1
Accounting policies
Company information

Carron Medical Services Limited is a private company limited by shares incorporated in Scotland. The registered office is 23, Ferguson Drive, Falkirk, Scotland, FK2 8QA.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.4
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

CARRON MEDICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 3 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
1
1
3
Current liabilities
2026
2025
£
£
Corporation tax
4,650
4,567
Other payables
9,896
9,837
14,546
14,404
4
Called up share capital
2026
2025
2026
2025
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A Shares of £1 each
52
52
52
52
Ordinar B Shares of £1 each
48
48
48
48
100
100
100
100
2026-03-312025-04-01falsefalsefalse28 May 2026CCH SoftwareCCH Accounts Production 2026.100The principal activity of the company continued to be that of medical services.
Mrs E I J MuircroftDr G Muircroft
SC3760942025-04-012026-03-31SC3760942026-03-31SC3760942025-03-31SC376094core:CurrentFinancialInstrumentscore:WithinOneYear2026-03-31SC376094core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-31SC376094core:CurrentFinancialInstruments2026-03-31SC376094core:CurrentFinancialInstruments2025-03-31SC376094core:ShareCapital2026-03-31SC376094core:ShareCapital2025-03-31SC376094core:RetainedEarningsAccumulatedLosses2026-03-31SC376094core:RetainedEarningsAccumulatedLosses2025-03-31SC376094core:ShareCapitalOrdinaryShareClass12026-03-31SC376094core:ShareCapitalOrdinaryShareClass12025-03-31SC376094core:ShareCapitalOrdinaryShareClass22026-03-31SC376094core:ShareCapitalOrdinaryShareClass22025-03-31SC376094core:ShareCapitalOrdinaryShares2026-03-31SC376094core:ShareCapitalOrdinaryShares2025-03-31SC376094bus:Director22025-04-012026-03-31SC3760942024-04-012025-03-31SC376094bus:OrdinaryShareClass12025-04-012026-03-31SC376094bus:OrdinaryShareClass22025-04-012026-03-31SC376094bus:OrdinaryShareClass12026-03-31SC376094bus:OrdinaryShareClass12025-03-31SC376094bus:OrdinaryShareClass22026-03-31SC376094bus:OrdinaryShareClass22025-03-31SC376094bus:AllOrdinaryShares2026-03-31SC376094bus:AllOrdinaryShares2025-03-31SC376094bus:PrivateLimitedCompanyLtd2025-04-012026-03-31SC376094bus:SmallCompaniesRegimeForAccounts2025-04-012026-03-31SC376094bus:FRS1022025-04-012026-03-31SC376094bus:AuditExemptWithAccountantsReport2025-04-012026-03-31SC376094bus:Director12025-04-012026-03-31SC376094bus:FullAccounts2025-04-012026-03-31xbrli:purexbrli:sharesiso4217:GBP